SPRY,ARS Pharmaceuticals, Inc. | Healthcare

Healthcare

SPRY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ARS Pharmaceuticals, Inc.SPRY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

1.37B

Revenue (ttm)

89.15M

Net Income (ttm)

8.00M

Shares Out

98.12M

EPS (ttm)

0.08

PE Ratio

172.88

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

969,514

Open

13.23

Previous Close

13.24

Day's Range

13.23 - 14.35

52-Week Range

7.55 - 18.51

Beta

0.98

Analysts

Strong Buy

Price Target

28.75 (+106.24%)

Earnings Date

May 8, 2025

Description >

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions.

It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.

The company was founded in 2015 and is based in San Diego, California.

Latest News >

PRESS DIGEST-New York Times business news - May 16

May 15, 2024

May 16 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Netflix ( NFLX ) announced a three-season deal with the National Football League on Wednesday that will include showing two Christmas Day games on its service this year, making...

Investors reach for riskier assets as fear seeps out of markets

May 15, 2024

NEW YORK (Reuters) - U.S. stocks are at fresh records, bitcoin is soaring and investors are spurning insurance against portfolio declines as evidence that the economy is headed for a so-called soft landing whets market participants' appetite for risk. Call it the Goldilocks trade - a bet that the Federal Reserve will be able to tame inflation while keeping growth...

GRAPHIC-Investors reach for riskier assets as fear seeps out of markets

May 15, 2024

NEW YORK, May 16 (Reuters) - U.S. stocks are at fresh records, bitcoin is soaring and investors are spurning insurance against portfolio declines as evidence that the economy is headed for a so-called soft landing whets market participants' appetite for risk. Call it the Goldilocks trade - a bet that the Federal Reserve will be able to tame inflation while...

How easyJet's bet on holidays paid off

May 15, 2024

LONDON (Reuters) - EasyJet's ( EJTTF ) big bets on package holidays and better-located airports are helping it win customers, its CEO and investors say, even as concerns linger about the high cost of the strategy for an airline known for its no-frills service. The turnaround is part of a years-long effort by CEO Johan Lundgren to cut debt, revive...